文献速递肝病消化道肿瘤与早癌

马兜铃酸诱导小鼠与人类肝癌的突变特征

The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
PubMed 文献 · Hepatology · 2019-11-06

研究通过给予小鼠马兜铃酸I(AAI)单独或联合四氯化碳(CCl4),证明AAI暴露可剂量依赖性地诱导小鼠肝癌,包括肝细胞癌(HCC)及HCC与肝内胆管癌混合型。基因组分析揭示AAI导致DNA损伤和AAI-DNA加合物,通过特征性腺嘌呤至胸腺嘧啶颠换引发肿瘤,且AA相关突变特征主要见于人类肝癌(尤其中国)。在随机选取的中国HCC患者癌旁肝组织中,25.8%(16/62)检测到AAI-DNA加合物。

要点

  • AAI暴露可剂量依赖性地直接诱导小鼠肝癌,包括HCC和混合型HCC-ICC。
  • AAI通过AAI-DNA加合物和特征性A>T颠换驱动肝癌发生,复发性突变涉及Harvey鼠肉瘤病毒癌基因。
  • 中国HCC患者癌旁肝组织中AAI-DNA加合物检出率为25.8%(16/62)。

核心结论

  • 马兜铃酸暴露可直接诱导小鼠肝癌,并具有特征性突变过程,为AA相关人类肝癌的预防和诊断提供了证据。

研究设计与样本

  • 研究采用小鼠模型,包括磷酸酶及张力蛋白同源物(Pten)缺陷小鼠,给予马兜铃酸I(AAI)单独或联合四氯化碳(CCl4)处理。
  • 对小鼠肝癌及随机选取的中国HCC患者癌旁肝组织(62例)进行基因组分析和AAI-DNA加合物检测。

主要发现

  • AAI暴露以剂量依赖方式诱导小鼠肝癌,包括肝细胞癌(HCC)和HCC与肝内胆管癌混合型。
  • AAI暴露还增强了CCl4处理或Pten缺陷小鼠的肿瘤发生。
  • AAI导致DNA损伤和AAI-DNA加合物,通过特征性腺嘌呤至胸腺嘧啶颠换引发肝癌,基因组分析显示Harvey鼠肉瘤病毒癌基因复发性突变。
  • AA相关突变特征主要见于人类肝癌,尤其来自中国的肝癌。
  • 在随机选取的中国HCC患者癌旁肝组织中,25.8%(16/62)检测到AAI-DNA加合物。

关键数值与推荐

  • AAI-DNA加合物在中国HCC患者癌旁肝组织中的检出率为25.8%(16/62)。
  • 基于系统发育分析,特征性突变见于AA相关小鼠和人类肝癌的起始恶性克隆中。
  • 肿瘤蛋白p53和Janus激酶1的突变倾向于在AA影响的人类肿瘤中显著富集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Aristolochic acid (AA) exposure has been statistically associated with human liver cancers. However, direct evidence of AA exposure-induced liver cancer is absent. This study aims to establish a direct causal relationship between AA exposure and liver cancers based on a mouse model and then explores the AA-mediated genomic alterations that could be implicated in human cancers with AA-associated mutational signature. APPROACH AND RESULTS: We subjected mice, including phosphatase and tensin homolog (Pten)-deficient ones, to aristolochic acid I (AAI) alone or a combination of AAI and CCl4 . Significantly, AAI exposure induced mouse liver cancers, including hepatocellular carcinoma (HCC) and combined HCC and intrahepatic cholangiocarcinoma, in a dose-dependent manner. Moreover, AAI exposure also enhanced tumorigenesis in these CCl4 -treated or Pten-deficient mice. AAI led to DNA damage and AAI-DNA adduct that could initiate liver cancers through characteristic adenine-to-thymine transversions, as indicated by comprehensive genomic analysis, which revealed recurrent mutations in Harvey rat sarcoma virus oncogene. Interestingly, an AA-associated mutational signature was mainly implicated in human liver cancers, especially from China. Moreover, we detected the AAI-DNA adduct in 25.8% (16/62) of paratumor liver tissues from randomly selected Chinese patients with HCC. Furthermore, based on phylogenetic analysis, the characteristic mutations were found in the initiating malignant clones in the AA-implicated mouse and human liver cancers where the mutations of tumor protein p53 and Janus kinase 1 were prone to be significantly enriched in the AA-affected human tumors. CONCLUSIONS: This study provides evidence for AA-induced liver cancer with the featured mutational processes during malignant clonal evolution, laying a solid foundation for the prevention and diagnosis of AA-associated human cancers, especially liver cancers.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lu ZN, Luo Q, Zhao LN, et al. The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers. Hepatology. 2019. PMID: 31692012. doi:10.1002/hep.30863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。